EORTC Medical Director Dr Vassilis Golfinopoulos talks about the aims of SPECTA
1 Dec 2014
Hear EORTC Medical Director Dr Vassilis Golfinopoulos talk about the aims of SPECTA (Screening Patients for Efficient Clinical Trial Access) and catch up on other news from 26th EORTC – NCI – AACR symposium on molecular targets in cancer therapeutics in Barcelona.
Related News
Meet the new EORTC Board
9 Jul 2024
We are pleased to announce the release of the EORTC 2023 Annual Report
17 Jun 2024
Dr Denis Lacombe, EORTC CEO, appointed stakeholder co-chair of ACT EU advisory group
24 May 2024
Clinical Trials Day 2024: a Q&A on pragmatic clinical trials
20 May 2024
EORTC/EMA workshop suggests an international way forward for treatment optimisation studies
8 May 2024
EORTC’s Participation at the ESTRO Congress 2024
29 Apr 2024
EORTC: Advancing research and treatment for rare cancers
29 Feb 2024
EORTC Fellowship Programme: celebrating more than 20 years of impactful collaboration
22 Feb 2024
Appointment of Malte Peters as EORTC Strategic Alliance Officer
9 Feb 2024
Unique series of workshops in partnership with the European Medicines Agency (EMA)
7 Feb 2024
